Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

Healthcare Cannabis
THC Biomed Intl Ltd. is a Canada-based cannabis company. The Company is engaged in the production of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The Company is also engaged in scientific research and the development of products and services, with patient safety as a guiding principle. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho).


CSE:THC - Post by User

THC Biomed Intl Ltd > Analyst upgrade
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(5)
•••
Comment by Petespipeon Mar 03, 2021 11:20am
190 Views
Post# 32704854

RE:RE:RE:Analyst upgrade

RE:RE:RE:Analyst upgrade
winnerscircle wrote: Also a nice big chunk of options at .42 expire March 8.......sooo maybe some movement once thats off the books........ based on industry peers,there is no reason $THC shouldn't be trading $250mill+ marketcap in the near future ......jmo


Agreed, THC Biomed should be trading above$1.50/share. I'm still confident that we will hit $3.50 plus once more investors take notice
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities